13F

Investor

Newtyn Management, LLC

CIK 0001569241 · filed 2026-05-15 · SEC filing

13F book

$935.8M

Positions

33

10 new · 8 sold

Largest name

11.5%

Enviri Corp · NVRI

Est. mark

−$132.3M

Price effect on 23 names still held. Flow $122.8M.
NameTickerSharesValueWeightEst. markChange
Enviri CorpNVRI5.5M$108M11.5%$7.82MAdded$25.5M
Theravance Biopharma, Inc.TBPH4.84M$78.6M8.4%−$10.7MAdded−$1.87M
Quidelortho CorpQDEL4.56M$74.9M8.0%−$36.6MAdded−$11.2M
Array Digital Infrastructure1.62M$74.6M8.0%−$12.1MCut−$16.6M
Commscope Hldg Co IncVISN3.76M$68.5M7.3%$155.3KAdded$28.3M
Indivior Pharmaceuticals, Inc.INDV2M$61M6.5%New
Apartment Invt & Mgmt Co12.2M$49.7M5.3%−$17.2MAdded−$4.98M
Teleflex IncTFX400K$47.8M5.1%New
Resolute Hldgs Mgmt Inc242.4K$39.3M4.2%−$10.7MHeld
Cannae Hldgs Inc3.27M$37.1M4.0%−$14.2MCut−$18.7M
Par Technology CorpPAR2.73M$36.4M3.9%−$9.75MAdded$21M
USA Rare Earth, Inc.USAR2.34M$35.4M3.8%New
Weave Communications, Inc.WEAV7M$32.3M3.5%New
Cogent Communications Hldgs1.6M$30.1M3.2%−$3.81MAdded−$40K
Magnera CorpMAGN2.76M$26.2M2.8%−$13.3MAdded−$9.48M
Brightview Hldgs Inc2.1M$24.8M2.6%−$1.85MHeld
Compass Minerals Intl Inc770K$18M1.9%$2.86MCut$1.82M
Spectrum Brands Hldgs Inc NeSPB185K$13.6M1.5%$2.7MCut−$1.13M
Rocket Pharmaceuticals Inc3.17M$11.3M1.2%$185.5KAdded$2.03M
1 800 Flowers Com IncFLWS3.5M$10.6M1.1%−$3.12MHeld
Destiny Tech100 Inc.DXYZ345K$9.24M1.0%New
Ni Hldgs Inc670K$8.64M0.9%−$274.7KHeld
Ultragenyx Pharmaceutical In400K$8.38M0.9%−$606.6KAdded$1.57M
GRAIL, Inc.GRAL150K$7.75M0.8%−$5.09MHeld
Ataibeckley Inc Com ShsATAI1.78M$6.31M0.7%New
Franklin Str Pptys Corp7.15M$4.75M0.5%−$2.01MHeld
Zooz Strategy Ltd13.4M$4.03M0.4%−$1.84MCut−$2.05M
Mereo Biopharma Group PlcMREO7.08M$2.34M0.3%−$19.5KAdded$2.24M
Wave Life Sciences Ltd.WVE300K$2.17M0.2%−$2.92MHeld
Green Dot CorpGDOT142.6K$1.6M0.2%New
Uniqure Nv87.7K$1.43M0.2%New
Elme CommunitiesELME310.3K$623.6K0.1%New
Seritage Growth Pptys41.1K$115.5K0.0%New

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.